Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
2006 1
2007 1
2009 2
2011 1
2012 2
2013 1
2014 3
2015 2
2017 1
2018 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Les études post-inscriptions en France, quels enjeux pour les dispositifs médicaux.
Levesque K, Coqueblin C, Guillot B; et les participants à la table ronde N°3 de Giens XXIX; Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N. Levesque K, et al. Among authors: pitel s. Therapie. 2014 Jul-Aug;69(4):303-12. doi: 10.2515/therapie/2014047. Therapie. 2014. PMID: 27393225 French. No abstract available.
Centaur antibodies: Engineered chimeric equine-human recombinant antibodies.
Rosenfeld R, Alcalay R, Zvi A, Ben-David A, Noy-Porat T, Chitlaru T, Epstein E, Israeli O, Lazar S, Caspi N, Barnea A, Dor E, Chomsky I, Pitel S, Makdasi E, Zichel R, Mazor O. Rosenfeld R, et al. Among authors: pitel s. Front Immunol. 2022 Aug 19;13:942317. doi: 10.3389/fimmu.2022.942317. eCollection 2022. Front Immunol. 2022. PMID: 36059507 Free PMC article.
Specific barriers to the conduct of randomised clinical trials on medical devices.
Neugebauer EAM, Rath A, Antoine SL, Eikermann M, Seidel D, Koenen C, Jacobs E, Pieper D, Laville M, Pitel S, Martinho C, Djurisic S, Demotes-Mainard J, Kubiak C, Bertele V, Jakobsen JC, Garattini S, Gluud C. Neugebauer EAM, et al. Among authors: pitel s. Trials. 2017 Sep 13;18(1):427. doi: 10.1186/s13063-017-2168-0. Trials. 2017. PMID: 28903769 Free PMC article. Review.
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge.
Nechooshtan R, Ehrlich S, Vitikainen M, Makovitzki A, Dor E, Marcus H, Hefetz I, Pitel S, Wiebe M, Huuskonen A, Cherry L, Lupu E, Sapir Y, Holtzman T, Aftalion M, Gur D, Tamir H, Yahalom-Ronen Y, Ramot Y, Kronfeld N, Zarling D, Vallerga A, Tchelet R, Nyska A, Saloheimo M, Emalfarb M, Ophir Y. Nechooshtan R, et al. Among authors: pitel s. Vaccines (Basel). 2022 Dec 11;10(12):2119. doi: 10.3390/vaccines10122119. Vaccines (Basel). 2022. PMID: 36560529 Free PMC article.
Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry.
Madmon M, Shamai Yamin T, Pitel S, Belay C, Segula Y, Toister E, Hindi A, Cherry L, Ophir Y, Zichel R, Mimran A, Diamant E, Weissberg A. Madmon M, et al. Among authors: pitel s. Molecules. 2022 Dec 22;28(1):73. doi: 10.3390/molecules28010073. Molecules. 2022. PMID: 36615269 Free PMC article.
Post-approval studies in France, challenges facing medical devices.
Levesque K, Coqueblin C, Guillot B; participants of round table n3 of Giens XXIX : Aubourg Lucie 4 Avouac Bernard 5 Carbonneil Cédric 6; Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N. Levesque K, et al. Among authors: pitel s. Therapie. 2014 Jul-Aug;69(4):303-21. doi: 10.2515/therapie/2014051. Epub 2014 Aug 12. Therapie. 2014. PMID: 25230354 English, French.
17 results